Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50004281
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481111(CHEMBL566647)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481110(CHEMBL586043)
Affinity DataIC50: 0.700nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481112(CHEMBL567711)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481108(CHEMBL566665)
Affinity DataIC50: 2.40nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481114(CHEMBL566043)
Affinity DataIC50: 7nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481108(CHEMBL566665)
Affinity DataIC50: 14nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481106(CHEMBL571088)
Affinity DataIC50: 17nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481112(CHEMBL567711)
Affinity DataIC50: 20nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481109(CHEMBL566666)
Affinity DataIC50: 24nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481113(CHEMBL568359)
Affinity DataIC50: 26nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481114(CHEMBL566043)
Affinity DataIC50: 26nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481109(CHEMBL566666)
Affinity DataIC50: 28nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481092(CHEMBL566655)
Affinity DataIC50: 30nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481111(CHEMBL566647)
Affinity DataIC50: 48nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481110(CHEMBL586043)
Affinity DataIC50: 49nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8732((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...)
Affinity DataIC50: 50nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481113(CHEMBL568359)
Affinity DataIC50: 55nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481107(CHEMBL565827)
Affinity DataIC50: 71nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus (strain MRSA252))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481106(CHEMBL571088)
Affinity DataIC50: 132nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli (strain K12))
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8732((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...)
Affinity DataIC50: 139nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2020
Entry Details Article
PubMed